Latest California Healthline Stories
A new study shows that educational sessions about high blood pressure at African American barbershops, coupled with prescribing and helping to manage medication, reduced hypertension rates significantly.
A new study followed patients with severe chronic pain for a year and found that opioids relieved pain and increased function no better than common drugs like acetaminophen and lidocaine. But the opioids carry the risk of more serious side effects, including addiction and death.
Saving the lives of people with the bleeding disorder can require high doses of expensive blood-clotting factor. Taxpayers foot much of the bill as manufacturers profit enormously.
The effort, overseen by the county’s health services department, aims to improve care for a population with high rates of chronic disease, mental illness and drug addiction.
A Bay Area public health campaign harnesses the power of poetry to confront the root causes of a diabetes epidemic that is disproportionately hitting minority youth and those from low-income homes.
The center, driven by California’s legalization of marijuana, will study the medical, social and economic impacts of making pot widely accessible. Two top concerns: investigating marijuana as a potential substitute for opioids and providing the nascent cannabis industry with signposts for responsible behavior.
Orange County Superior Court judge says “media blitzkrieg” jeopardized chances that the nation’s third-largest health insurer could get a fair jury trial if the trial started this week, as planned. The company is being sued by a man who claims it improperly denied him care for a rare immune system disorder.
Agencies sometimes turn away Medicare beneficiaries with chronic health problems by incorrectly claiming Medicare won’t pay their services, say patient advocates.
Doctors are advising patients to be sure to fill medication orders now or are giving away drugs to make sure children have enough if their insurance disappears.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.